Pfizer

Exonhit, Pfizer collaborate in Alzheimer’s research

Tuesday, October 11, 2011 02:26 PM

Exonhit has entered into a research agreement with Pfizer for the identification of new Alzheimer's disease biomarkers using Exonhit's Genome-Wide SpliceArray (GWSA) platform.

More... »

Puma Biotech, Pfizer ink licensing agreement for Nertatinib

Thursday, October 6, 2011 01:01 PM

Puma Biotechnology, has signed an agreement with Pfizer to license the worldwide commercial rights to neratinib, a potent, irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, ErbB1 (EGFR), ErbB2 (HER2) and ErbB4 (HER4) kinases.  Neratinib is being studied in the neoadjuvant, adjuvant and metastatic settings in patients with HER2/ErbB2 positive breast cancer.

More... »

Drug sponsors join research partnership to accelerate drug discovery

Thursday, September 29, 2011 01:21 PM

In a bid to save both time and money, some of the industry's biggest names are experimenting with new ways to pool early-stage research, effectively taking a leaf out of the "open-source" manual that gave the world Linux software, according to Reuters.

More... »

Pfizer to cut 220 jobs in Spain

Thursday, September 22, 2011 11:41 AM

Pfizer has unveiled plans to cut its workforce in Spain by 11%, or 220 staff, driven by the financial crisis in Europe and regulatory moves in the country to reduce its healthcare spend, according to PharmaTimes.

More... »

Pfizer to invest $200 million in Irish facility

Tuesday, September 20, 2011 01:33 PM

Pfizer has announced that it is to invest $200 million at its Grange Castle biotechnology manufacturing facility in Clondalkin, Co Dublin, according to PharmaTimes.

More... »

Icon CEO Peter Gray to step down after nine years; CFO Ciaran Murray takes the helm as of Oct. 1

Monday, September 12, 2011 08:02 AM

Peter Gray, CEO of Icon since 2002, will step down as of Oct. 1. The announcement, which came last week, surprised many in the industry.  Icon’s board has appointed Ciaran Murray, who has been Icon’s CFO for the last six years, to succeed Gray as CEO.

More... »

Icon and Bristol-Myers Squibb build on strategic partnership, extending it to early-phase work

Monday, September 5, 2011 08:00 AM

Icon and Bristol-Myers Squibb (BMS) have inked a preferred-provider agreement for early-phase development. This constitutes the CRO’s second sizable agreement with BMS; in June 2010, the two formed a strategic partnership, with Icon focused on providing global support for the drug developer’s clinical development pipeline.

More... »

Pfizer to create 400 jobs in Massachusetts

Friday, September 2, 2011 10:50 AM

Pfizer is gobbling up some prime biotech real estate in Cambridge, MA. The New York-based pharma company is adding space for 400 employees at the heart of the biotech R&D hub in Kendall Square, according to Xconomy Boston.

More... »

Roche CEO says diagnostics will maintain its lead in targeted drugs

Thursday, September 1, 2011 02:15 PM

Roche expects a new generation of drugs targeted at specific groups of patients to make up half its portfolio in 10 years, a shift that is pushing the boundaries of modern medicine, according to Reuters.

More... »

The Research Network operates from former Pfizer site

Thursday, September 1, 2011 10:25 AM

A company set up by a group of former Pfizer employees is one of the first businesses to be based at the east Kent site which Pfizer is leaving, according to BBC Mobile.

More... »